Literature DB >> 14749157

Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study.

Demosthenes B Panagiotakos1, Christos Pitsavos, Christina Chrysohoou, John Skoumas, Constadina Masoura, Pavlos Toutouzas, Christodoulos Stefanadis.   

Abstract

PURPOSE: We sought to investigate the effect of secondhand smoke exposure on inflammatory markers related to cardiovascular disease.
METHODS: During 2001 to 2002, we randomly selected a stratified (age-sex) sample of adults without clinical evidence of cardiovascular disease. Exposure to secondhand smoke (>30 minutes per day and > or =1 day per week) was recorded. Multivariate regression analysis was used to evaluate the effects of exposure to secondhand smoke on levels of C-reactive protein, fibrinogen, homocysteine, and oxidized low-density lipoprotein (LDL) cholesterol, and on white blood cell count.
RESULTS: One hundred and thirty-seven (38%) of the 357 men who had never smoked and 211 (33%) of the 638 never-smoking women reported current exposure to secondhand smoke. Compared with those who were not exposed to secondhand smoke, those exposed more than 3 days per week had higher white blood cell counts (by 600 cells per microL; P = 0.02), as well as higher levels of C-reactive protein (by 0.08 mg/dL; P = 0.03), homocysteine (by 0.4 micromol/L; P = 0.002), fibrinogen (by 5.2 mg/dL; P = 0.4), and oxidized LDL cholesterol (by 3.3 mg/dL; P = 0.03), after adjusting for several potential confounders.
CONCLUSION: Our findings suggest another pathophysiological mechanism by which exposure to secondhand smoke is associated with the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749157     DOI: 10.1016/j.amjmed.2003.07.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  49 in total

1.  How acute and reversible are the cardiovascular risks of secondhand smoke?

Authors:  Terry F Pechacek; Stephen Babb
Journal:  BMJ       Date:  2004-04-24

2.  Passive smoking's role in diabetes.

Authors:  Demosthenes B Panagiotakos; Christos Pitsavos
Journal:  BMJ       Date:  2006-05-06

Review 3.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

4.  Secondhand Smoke Exposure and Preclinical Markers of Cardiovascular Risk in Toddlers.

Authors:  Judith A Groner; Hong Huang; Mandar S Joshi; Nicholas Eastman; Lisa Nicholson; John Anthony Bauer
Journal:  J Pediatr       Date:  2017-07-12       Impact factor: 4.406

5.  Passive and Active Tobacco Exposure and Children's Lipid Profiles.

Authors:  Joseph Zakhar; Stephen M Amrock; Michael Weitzman
Journal:  Nicotine Tob Res       Date:  2015-07-17       Impact factor: 4.244

6.  Objectively measured secondhand smoke exposure and risk of cardiovascular disease: what is the mediating role of inflammatory and hemostatic factors?

Authors:  Mark Hamer; Emmanuel Stamatakis; Mika Kivimaki; Gordon D Lowe; G David Batty
Journal:  J Am Coll Cardiol       Date:  2010-06-29       Impact factor: 24.094

7.  Air pollution and circulating biomarkers of oxidative stress.

Authors:  Ralph J Delfino; Norbert Staimer; Nosratola D Vaziri
Journal:  Air Qual Atmos Health       Date:  2011-03-01       Impact factor: 3.763

8.  Changes in plasma IL4, TNFá and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan.

Authors:  T H Merghani; A Saeed; A Alawad
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

Review 9.  C-reactive protein as a predictor of disease in smokers and former smokers: a review.

Authors:  S Tonstad; J L Cowan
Journal:  Int J Clin Pract       Date:  2009-08-29       Impact factor: 2.503

10.  Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women.

Authors:  B J Jefferis; G D O Lowe; P Welsh; A Rumley; D A Lawlor; S Ebrahim; C Carson; M Doig; C Feyerabend; L McMeekin; S G Wannamethee; D G Cook; P H Whincup
Journal:  Atherosclerosis       Date:  2009-07-30       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.